EcoDrugPlus

Sphingosine Kinase 2-Like

Ensembl ID : ENSACLG00000020962
Gene Symbol: LOC113031460
2 Cross references
202 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSACLG00000022921
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSACLG00000004868
Gene Symbol: LOC113035327
3 Cross references
211 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSACLG00000024735
Gene Symbol: SRD5A2
3 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSACLG00000022809
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSACLG00000005634
Gene Symbol: TACR1
3 Cross references
214 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSACLG00000008350
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSACLG00000018656
Gene Symbol: TACR3
4 Cross references
172 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSACLG00000004349
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSACLG00000005556
Gene Symbol: TBXAS1
1 Cross references
210 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSACLG00000025570
Gene Symbol: TBXA2R
3 Cross references
193 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSACLG00000005928
Gene Symbol: LOC113027105
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).